AAAAAA
Results:
1-10
|
Results: 10
Authors:
GAUSE BL
SHARFMAN WH
JANIK JE
CURTI BD
STEIS RG
URBA WJ
SMITH JW
ALVORD WG
LONGO SL
Citation: Bl. Gause et al., A PHASE-II STUDY OF CARBOPLATIN, CISPLATIN, INTERFERON-ALPHA, AND TAMOXIFEN FOR PATIENTS WITH METASTATIC MELANOMA, Cancer investigation, 16(6), 1998, pp. 374-380
Authors:
JANIK JE
MILLER LL
LONGO DL
POWERS GC
URBA WJ
KOPP WC
GAUSE BL
CURTI BD
FENTON RG
OPPENHEIM JJ
CONLON KC
HOLMLUND JT
SZNOL M
SHARFMAN WH
STEIS RG
CREEKMORE SP
ALVORD WG
BEAUCHAMP AE
SMITH JW
Citation: Je. Janik et al., PHASE-II TRIAL OF INTERLEUKIN-1-ALPHA AND INDOMETHACIN IN TREATMENT OF METASTATIC MELANOMA, Journal of the National Cancer Institute, 88(1), 1996, pp. 44-49
Authors:
FENTON RG
STEIS RG
MADARA K
ZEA AH
OCHOA AC
JANIK JE
SMITH JW
GAUSE BL
SHARFMAN WH
URBA WJ
HANNA MG
DEJAGER RL
COYNE MX
CROUCH RD
GRAY P
BEVERIDGE J
CREEKMORE SP
HOLMLUND J
CURTI BD
SZNOL M
LONGO DL
Citation: Rg. Fenton et al., A PHASE-I RANDOMIZED STUDY OF SUBCUTANEOUS ADJUVANT IL-2 IN COMBINATION WITH AN AUTOLOGOUS TUMOR VACCINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 364-374
Authors:
GAUSE BL
SZNOL M
KOPP WC
JANIK JE
SMITH JW
STEIS RG
URBA WJ
SHARFMAN W
FENTON RG
CREEKMORE SP
HOLMLUND J
CONLON KC
VANDERMOLEN LA
LONGO DL
Citation: Bl. Gause et al., PHASE-I STUDY OF SUBCUTANEOUSLY ADMINISTERED INTERLEUKIN-2 IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2234-2241
Authors:
HOLMLUND JT
KOPP WC
WILTROUT RH
LONGO DL
URBA WJ
JANIK JE
SZNOL M
CONLON KC
FENTON RG
HORNUNG R
MADARA K
SHIELDS MA
SMITH JW
SHARFMAN W
STEIS RG
EWEL C
MALSPEIS L
CREEKMORE SP
Citation: Jt. Holmlund et al., A PHASE-I CLINICAL-TRIAL OF FLAVONE-8-ACETIC ACID IN COMBINATION WITHINTERLEUKIN-2, Journal of the National Cancer Institute, 87(2), 1995, pp. 134-136
Authors:
SHARFMAN WH
URBA WJ
SMITH JW
JANIK JE
CURTI BD
GAUSE BL
HOLMLUND JT
STEIS RG
BEAUCHAMP AE
LONGO DL
Citation: Wh. Sharfman et al., PHASE I II TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, ZIDOVUDINE AND DIPYRIDAMOLE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, RENAL-CELL CARCINOMA AND MALIGNANT-MELANOMA/, International journal of oncology, 6(3), 1995, pp. 579-583
Authors:
STEIS RG
LONGO DL
Citation: Rg. Steis et Dl. Longo, CLINICAL RELEVANCE OF RECOMBINANT INTERFERON-ALPHA(2A) ANTIBODIES IN PATIENTS WITH HAIRY-CELL LEUKEMIA, Journal of interferon research, 14(4), 1994, pp. 207-209
Authors:
KASTENSPORTES C
ZAKNOEN S
STEIS RG
CHAN WC
WINTON EF
WALDMANN TA
Citation: C. Kastensportes et al., T-CELL RECEPTOR GENE REARRANGEMENT IN T-CELL LARGE GRANULAR LEUKOCYTELEUKEMIA - PREFERENTIAL-V-ALPHA BUT DIVERSE-J-ALPHA USAGE IN ONE OF 5PATIENTS, Blood, 83(3), 1994, pp. 767-775
Authors:
HOROWITZ ME
KINSELLA TJ
WEXLER LH
BELASCO J
TRICHE T
TSOKOS M
STEINBERG SM
MCCLURE L
LONGO DL
STEIS RG
GLATSTEIN E
PIZZO PA
MISER JS
Citation: Me. Horowitz et al., TOTAL-BODY IRRADIATION AND AUTOLOGOUS BONE-MARROW TRANSPLANT IN THE TREATMENT OF HIGH-RISK EWINGS-SARCOMA AND RHABDOMYOSARCOMA, Journal of clinical oncology, 11(10), 1993, pp. 1911-1918
Authors:
KASTENSPORTES C
STEIS RG
WALDMANN TA
Citation: C. Kastensportes et al., T-CELL RECEPTOR GENE REARRANGEMENT WITH PREFERENTIAL-V-ALPHA BUT DIVERSE-J-ALPHA USAGE IN CLONAL-T-GAMMA LYMPHOPROLIFERATIVE DISEASE, Blood, 82(10), 1993, pp. 10000047-10000047
Risultati:
1-10
|